Format

Send to

Choose Destination
Oncoscience. 2017 Feb 24;4(1-2):1-2. doi: 10.18632/oncoscience.338. eCollection 2017 Jan.

Nicotinamide riboside or IL-17A signaling blockers to prevent liver disorders.

Author information

1
Cancer Cell Biology Programme, Growth Factors, Nutrients and Cancer Group, Spanish National Cancer Research Centre, CNIO, Madrid, Spain.

KEYWORDS:

HCC; IL-17A; NAD+; NASH; Nicotinamide riboside

Conflict of interest statement

CONFLICTS OF INTEREST No conflicts of interest were disclosed.

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center